Showing results (11-20 of 3,393) with videos related to
Sort By:
Pageof 340
Journal of Neuro-Oncology|August 20, 2020
Temozolomide treatment outcomes and immunotherapy efficacy in brain tumorKelly M Hotchkiss, John H SampsonSeminars in Radiation Oncology|September 16, 2014
Recurrent malignant gliomasJohn P Kirkpatrick, John H SampsonNeurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|June 30, 2009
Toward effective immunotherapy for the treatment of malignant brain tumorsDuane A Mitchell, John H SampsonExpert Opinion on Biological Therapy|July 14, 2009
The PEPvIII-KLH (CDX-110) vaccine in glioblastoma multiforme patientsAmy B Heimberger, John H SampsonSurgical Neurology|August 1, 1993
The gravitational shunt: an alternative approach to cerebrospinal fluid shuntingJ H Sampson, E R CardosoJournal of Neurosurgery|September 11, 1992
Facial pain due to vascular lesions of the brain stem relieved by dorsal root entry zone lesions in the nucleus caudalis. Report of two casesJ H Sampson, B S NasholdJournal of Neurosurgery|September 2, 2019
The current state of immunotherapy for gliomas: an eye toward the futurePeter E Fecci, John H SampsonThe Mount Sinai Journal of Medicine, New York|February 8, 2002
Subarachnoid hemorrhage presenting as post-dural puncture headache: a case reportJason B Wells, Ian H SampsonExpert Opinion on Pharmacotherapy|August 21, 2014
Standard of care and future pharmacological treatment options for malignant glioma: an urgent need for screening and identification of novel tumor-specific antigensKristen A Batich, John H SampsonNeuroimaging Clinics of North America|April 12, 2003
Clinical immunotherapy for brain tumorsPeter E Fecci, John H SampsonPageof 340